Regeneus Ltd [ASX:RGS] share price and news 2022

Company Description

Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Regeneus Ltd belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.regeneus.com.au.

This a small cap company with market cap of 33 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 -220 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how rgs dividend grows in the recent years.

No data